Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, Molecular therapy for Pulmonary Hypertension: E2F3 inhibits pulmonary hypertension via down regulation of its target gene, 18/January/2015, 17.33, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: This study suggests, for the first time, that E2F3, by decreasing the expression of its target genes, it may inhibit pulmonary hypertension. Thus, pharmacological formulations encompassing “E2F3 activators” may be used to treat pulmonary hypertension.
Amount: $ 300
Undisclosed information: How E2F3 inhibits the development of pulmonary hypertension
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
